Experimental human cytomegalovirus latency in CD14+ monocytes.
about
Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2Modeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived SystemsCurrent and potential treatments for ubiquitous but neglected herpesvirus infectionsBclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infectionCytomegalovirus, Macrophages and Breast Cancer.LPS promotes a monocyte phenotype permissive for human cytomegalovirus immediate-early gene expression upon infection but not reactivation from latencyPerivascular stromal cells as a potential reservoir of human cytomegalovirus.Cytomegalovirus latency and reactivation: recent insights into an age old problem.Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitroThe oncogenic potential of human cytomegalovirus and breast cancer.HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses.Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+R+ liver transplant patients.Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency.Human cytomegalovirus gene expression in long-term infected glioma stem cells.Human cytomegalovirus persistence.Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like ResponseHCMV Displays a Unique Transcriptome of Immunomodulatory Genes in Primary Monocyte-Derived Cell Types.Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model.The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?Differentiation-Coupled Induction of Human Cytomegalovirus Replication by Union of the Major Enhancer Retinoic Acid, Cyclic AMP, and NF-κB Response Elements.Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.Human embryonic stem cell lines model experimental human cytomegalovirus latency.Epigenetic control of cytomegalovirus latency and reactivation.Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations.The Expression of Human Cytomegalovirus MicroRNA MiR-UL148D during Latent Infection in Primary Myeloid Cells Inhibits Activin A-triggered Secretion of IL-6Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.Congenital cytomegalovirus infection: new prospects for prevention and therapyActivation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner.Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship.Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.Regulation of human cytomegalovirus transcription in latency: beyond the major immediate-early promoterFunctional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis.Human cytomegalovirus manipulation of latently infected cells.The intimate relationship between human cytomegalovirus and the dendritic cell lineage.Manipulation of host pathways by human cytomegalovirus: insights from genome-wide studies.
P2860
Q26744783-20D76453-C3CF-4369-A83C-D5F7C08B541EQ26799933-E04DAE5F-F108-414B-BE11-952E5BEF1EE9Q27023452-9C26BDF1-1A2F-41B3-B334-EEFCEF47F555Q30519179-9231FE04-4F1D-4F98-B119-7D2802EDA672Q33645055-C7CB4D00-6A1D-4ECA-9902-ECFFEC1460B0Q33678265-8E5639F9-198B-413B-B200-48483A1AE905Q33714313-D8E91A40-A356-4E65-A7B0-918F9DD4BC97Q33761454-6E85098F-0B20-4F69-AEDC-9F03208D928FQ34059073-CBD10357-3031-4982-A01E-D8C659017D53Q34081724-4D21A4B8-FA7B-496F-9AC1-DB6EAA7DBEB5Q34541265-08748485-0DC1-42A3-9B6C-E8340E7B8BA8Q34550472-3FB183B2-238B-40CA-8CCC-0DB4686FF5CFQ34720787-C597E751-D135-4CC8-A356-BF351C984DABQ34743747-FB67CD85-7EF8-4FFB-9B0E-F91503793E60Q35191037-1EFBD841-036A-4FB8-83E7-6DDBA693FADFQ35535809-A6D127E8-7782-4E17-B49E-708F93FEEB00Q35899274-3050A4E7-526B-41F8-80B8-AE0EC05EFD91Q36069672-148F97A7-501A-42E9-A8AB-11B23B48A6DFQ36168094-62D231AD-2451-4A05-BAFC-B17EA92545A4Q36171970-C274A897-1B78-4957-AB0D-CB4A550E640FQ36302615-68301F6E-BB05-4F23-B049-04365BD36B61Q36334306-7A054657-086D-4161-A29D-E7D966C7BBF6Q36432667-D85A89CE-7AD4-4FC2-9A20-10F775B84646Q36736662-35B6CEF4-B6D4-4D1F-B8E7-F0A3CC753680Q36862292-18C6D215-115F-478D-9151-1B4882AE1316Q36873797-AFF07DD7-37AF-49CC-B984-B9E84F33E413Q37015743-DB32190F-D3C8-4FB5-BA64-089FDC6AD386Q37123492-84BDBC80-AF59-42FD-AD91-008FDBF08257Q37153807-508AA696-DD4E-4F23-9E52-7A74BAB9625DQ37197940-782D6064-BFFF-4073-9F5F-2BAB70A8A3D7Q37254183-4FB1EA3C-7421-4D0E-9D8D-F998E51285D1Q37254205-ADDD4F40-5919-4270-9437-5C61A4FF28B4Q37630372-54A1FA5A-412C-4B37-9AE4-BC3B48276E6FQ38018936-7CAA4DB6-E5DF-472A-B96B-477FC948C1AFQ38053067-E4FDEE77-49B8-419E-815E-F08BFE86B1F3Q38111995-B435252A-D809-4F6E-802C-37F1E92782A3Q38118447-8ACEB98D-CDA3-4726-85A7-2459A680CEB4Q38166925-A2E191AA-DF9D-4E81-8EC0-181072B54A53Q38242199-BE350C48-4D70-4BE2-A1C8-2FA21055BF19Q38254758-9F6744C0-EE27-4FA3-B8FE-67848D0C217A
P2860
Experimental human cytomegalovirus latency in CD14+ monocytes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Experimental human cytomegalovirus latency in CD14+ monocytes.
@ast
Experimental human cytomegalovirus latency in CD14+ monocytes.
@en
Experimental human cytomegalovirus latency in CD14+ monocytes.
@nl
type
label
Experimental human cytomegalovirus latency in CD14+ monocytes.
@ast
Experimental human cytomegalovirus latency in CD14+ monocytes.
@en
Experimental human cytomegalovirus latency in CD14+ monocytes.
@nl
prefLabel
Experimental human cytomegalovirus latency in CD14+ monocytes.
@ast
Experimental human cytomegalovirus latency in CD14+ monocytes.
@en
Experimental human cytomegalovirus latency in CD14+ monocytes.
@nl
P2860
P356
P1476
Experimental human cytomegalovirus latency in CD14+ monocytes.
@en
P2093
Danna Hargett
Thomas E Shenk
P2860
P304
20039-20044
P356
10.1073/PNAS.1014509107
P407
P577
2010-11-01T00:00:00Z